Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Sell
11,396
-406
-3% -$45.8K 0.05% 156
2025
Q4
$1.48M Buy
11,802
+1,988
+20% +$253K 0.06% 133
2025
Q3
$1.31M Buy
9,814
+273
+3% +$35.8K 0.06% 132
2025
Q2
$1.3M Buy
9,541
+4,789
+101% +$632K 0.06% 127
2025
Q1
$630K Buy
4,752
+63
+1% +$8.02K 0.03% 158
2024
Q4
$530K Sell
4,689
-362
-7% -$41.8K 0.03% 161
2024
Q3
$576K Buy
5,051
+72
+1% +$7.9K 0.03% 153
2024
Q2
$517K Buy
4,979
+116
+2% +$12.3K 0.03% 149
2024
Q1
$553K Buy
4,863
+40
+0.8% +$4.58K 0.04% 145
2023
Q4
$531K Sell
4,823
-84
-2% -$8.39K 0.04% 141
2023
Q3
$475K Buy
4,907
+18
+0.4% +$1.89K 0.04% 129
2023
Q2
$533K Buy
+4,889
New +$521K 0.04% 121
2014
Q3
Sell
-6,582
Closed -$269K 76
2014
Q2
$269K Sell
6,582
-1,092
-14% -$42.9K 0.23% 52
2014
Q1
$289K Buy
+7,674
New +$296K 0.22% 51

Other funds holding ABT

GM Advisory Group's ABT Position: Q1 2026 in Review

GM Advisory Group reduced its Abbott (ABT) stake by 3.4% in Q1 2026, selling an estimated $45.8K and leaving 11,396 shares worth $1.17M. The position accounts for 0.05% of the portfolio, ranked #156.

GM Advisory Group first reported a position in ABT in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.48M in Q4 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • GM Advisory Group held 11,396 shares of Abbott worth $1.17M as of Q1 2026.
  • GM Advisory Group sold 406 Abbott shares in Q1 2026, an estimated $45.8K.
  • Abbott made up 0.05% of GM Advisory Group's portfolio in Q1 2026, its #156 holding.
  • GM Advisory Group first reported a position in Abbott in Q1 2014 and has held it in 14 quarters since.
  • GM Advisory Group's Abbott position peaked at $1.48M in Q4 2025.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.